DEVELOPMENT OF NOVEL NONAGONIST PPAR-GAMMA LIGANDS FOR LUNG CANCER TREATMENT

$412,703FY2015Department of the ArmyDOD

The General Hospital Corporation

Investigators

View source on USAspending →